New Series of Interactive Cardiology MCQs 10
Advanced Clinical Series
Cardiology MCQs: Part 10
Master-level assessment spanning complex hemodynamics, electrophysiology, structural interventions, and landmark clinical trials.
Live Score
0
/ 25
1. Which of the following represents the classic electrocardiographic hallmark of Brugada Syndrome Type 1?
2. During simultaneous right and left heart catheterization, which of the following hemodynamic profiles strongly favors Constrictive Pericarditis over Restrictive Cardiomyopathy?
3. Among patients undergoing Transcatheter Aortic Valve Replacement (TAVR), which valve design historically carries the highest risk of causing conduction blocks requiring a permanent pacemaker?
4. Which of the following genes represents the most common genetic mutation responsible for Hypertrophic Cardiomyopathy (HCM)?
5. Sacubitril, a key component of foundational heart failure therapy, exerts its clinical benefit via which specific mechanism of action?
6. Which of the following organisms belongs to the fastidious HACEK group, a known cause of culture-negative infective endocarditis?
7. According to ACC/AHA guidelines, which of the following patient profiles represents a Class I indication for Cardiac Resynchronization Therapy (CRT)?
8. Maternal use of which medication during the first trimester of pregnancy is classically associated with an increased risk of Ebstein anomaly in the fetus?
9. Which of the following is a hallmark physical examination finding indicative of cardiac tamponade?
10. Wellens Syndrome warns of a critical, impending occlusion of the proximal Left Anterior Descending (LAD) artery. What is its characteristic ECG pattern observed during a pain-free interval?
11. Which class of antihypertensive medications is strictly contraindicated in patients with Heart Failure with Reduced Ejection Fraction (HFrEF)?
12. In echocardiography, which empirical formula is utilized to estimate the Mitral Valve Area (MVA) based on the diastolic Pressure Half-Time (PHT)?
13. What was the primary conclusion of the landmark ISCHEMIA trial regarding the management of patients with stable, moderate-to-severe coronary artery disease?
14. During echocardiographic evaluation of a large pericardial effusion, which of the following findings is the MOST specific indicator of hemodynamic cardiac tamponade?
15. In a patient presenting with rapid Atrial Fibrillation with pre-excitation (Wolff-Parkinson-White syndrome), which drug class is absolutely contraindicated for rate control?
16. Which specific type of Atrial Septal Defect (ASD) is fundamentally an endocardial cushion defect and is highly associated with Down syndrome (Trisomy 21)?
17. PCSK9 inhibitors (such as Evolocumab and Alirocumab) radically lower LDL cholesterol through which molecular mechanism?
18. In patients with Congenital Long QT Syndrome Type 1 (LQT1), fatal arrhythmias (Torsades de Pointes) are most classically triggered by:
19. For a patient with ischemic cardiomyopathy (at least 40 days post-MI and > 90 days post-revascularization), which of the following establishes a Class I indication for a Primary Prevention Implantable Cardioverter-Defibrillator (ICD)?
20. When prescribing dual antiplatelet therapy after a PCI, which patient history finding is an ABSOLUTE contraindication to the use of Prasugrel?
21. In a patient suffering from third-degree (complete) AV block, which classic clinical sign may be observed in the jugular venous pulse (JVP)?
22. Which of the following medications is a dual Endothelin Receptor Antagonist (ERA) used in the treatment of Group 1 Pulmonary Arterial Hypertension (PAH)?
23. Which finding on Cardiac Magnetic Resonance (CMR) imaging is considered highly classic for Cardiac Amyloidosis?
24. In approximately 10% of the population with a "left-dominant" coronary circulation, the Posterior Descending Artery (PDA) arises from which vessel?
25. Which highly characteristic electrocardiographic finding in leads V1-V3 suggests the diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)?
Related Posts
About The Author
Johnson Francis
Former Professor of Cardiology, Calicut Govt. Medical Kozhikode, Kerala, India. Editor-in-Chief, BMH Medical Journal